Vynleads (VYND) Non Operating Interest Expenses (2020)

Vynleads (VYND) posted quarterly Non Operating Interest Expenses of -$990.0 for Q4 2020, down 1494.37% quarter-over-quarter from $71.0 in Q3 2020.

Vynleads (VYND) Non Operating Interest Expenses (2020) Analysis & Trends

Vynleads (VYND) has reported Non Operating Interest Expenses for 1 consecutive years, with -$990.0 the latest figure, recorded in Q4 2020.

In Q4 2020, Non Operating Interest Expenses changed N/A year-over-year to -$990.0; the TTM figure through Dec 2020 stood at $895.0 (changed N/A YoY), while the FY2020 annual figure was $895.0, changed N/A from the prior year.
Non Operating Interest Expenses fell to -$990.0 in Q4 2020 per VYND's latest filing, from $71.0 in the prior quarter.
Across five years, Non Operating Interest Expenses topped out at $1547.0 in Q2 2020 and bottomed at -$990.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Interest Expenses (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Vynleads	7.51 Mn	7.51 Mn	-2,028.00	-

Download Data